We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

Differential Diagnosis: Distinguishing Between Ghostwriting and Professional Medical Writing in Biomedical Journals—Reply

Xavier Bosch, MD, PhD1
[+] Author Affiliations
1Department of Internal Medicine, Hospital Clínic, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain
JAMA Intern Med. 2013;173(22):2092-2093. doi:10.1001/jamainternmed.2013.10387.
Text Size: A A A
Published online


In Reply Although I agree with Hamilton that focusing only on the negative angle of medical writing may create a distorted perception, history cannot be ignored. Writing in PLoS Medicine, Linda Logdberg1 illuminated her experience as a pharmaceutical company-sponsored medical writer. She asserted the following:

Indeed, publication planning is the practice by which drug companies create and divulge articles in biomedical journals and communications at conferences to plant strategic promotional information.2 Fugh-Berman and Dodgson3(pe35) have reported how professional medical writers are central to publication planning, stating that “[s]ponsored writing reflects sponsored messages” and that “[even] the most vigilant editor could not uncover all of the marketing messages embedded in manuscripts by publication planning professionals.”


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





December 9, 2013
Cindy W. Hamilton, PharmD
1Hamilton House, Virginia Beach, Virginia2Virginia Commonwealth University School of Pharmacy, Richmond
JAMA Intern Med. 2013;173(22):2091-2092. doi:10.1001/jamainternmed.2013.10420.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...